Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?

ABSTRACT Objective The objective of this study is to evaluate the performance of mathematical models used in non-invasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease (NAFLD) patients to determine when the patient needs to be referred to a hepatologist. Subjects and methods Pa...

Full description

Bibliographic Details
Main Authors: Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2017-02-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000300276&lng=en&tlng=en
_version_ 1818108231242743808
author Rodrigo Bremer Nones
Cláudia Pontes Ivantes
Maria Lucia Alves Pedroso
author_facet Rodrigo Bremer Nones
Cláudia Pontes Ivantes
Maria Lucia Alves Pedroso
author_sort Rodrigo Bremer Nones
collection DOAJ
description ABSTRACT Objective The objective of this study is to evaluate the performance of mathematical models used in non-invasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease (NAFLD) patients to determine when the patient needs to be referred to a hepatologist. Subjects and methods Patients referred by endocrinologists to the liver outpatient departments in two hospitals in Curitiba, Brazil, over a 72-month period were analyzed. The results calculated using the APRI, FIB 4, FORNS and NAFLD Fibrosis Score non-invasive liver fibrosis assessment models were analyzed and compared with histological staging of this population. Results Sixty-seven patients with NAFLD were analyzed. Forty-two of them (62.68%) were female, mean age was 54.76 (±9.63) years, mean body mass index 31.42 (±5.64) and 59 (88.05%) of the 67 cases had glucose intolerance or diabetes. A diagnosis of steatohepatitis was made in 45 (76.27%) of the 59 biopsied patients, and advanced liver fibrosis (stages 3 and 4) was diagnosed in 18 (26.86%) of the 67 patients in the study population. The FIB 4 and NAFLD Fibrosis Score models had a high negative predictive value (93.48% and 93.61%, respectively) in patients with severe liver fibrosis (stages 3 and 4). Conclusion In conclusion, use of the FIB 4 and NAFLD Fibrosis Score models in NAFLD patients allows a diagnosis of severe liver disease to be excluded.
first_indexed 2024-12-11T02:12:04Z
format Article
id doaj.art-5a5bff9fdf9e4bd1991e4d012657c1b2
institution Directory Open Access Journal
issn 2359-4292
language English
last_indexed 2024-12-11T02:12:04Z
publishDate 2017-02-01
publisher Brazilian Society of Endocrinology and Metabolism
record_format Article
series Archives of Endocrinology and Metabolism
spelling doaj.art-5a5bff9fdf9e4bd1991e4d012657c1b22022-12-22T01:24:16ZengBrazilian Society of Endocrinology and MetabolismArchives of Endocrinology and Metabolism2359-42922017-02-0161327628110.1590/2359-3997000000233S2359-39972017000300276Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?Rodrigo Bremer NonesCláudia Pontes IvantesMaria Lucia Alves PedrosoABSTRACT Objective The objective of this study is to evaluate the performance of mathematical models used in non-invasive diagnosis of liver fibrosis in nonalcoholic fatty liver disease (NAFLD) patients to determine when the patient needs to be referred to a hepatologist. Subjects and methods Patients referred by endocrinologists to the liver outpatient departments in two hospitals in Curitiba, Brazil, over a 72-month period were analyzed. The results calculated using the APRI, FIB 4, FORNS and NAFLD Fibrosis Score non-invasive liver fibrosis assessment models were analyzed and compared with histological staging of this population. Results Sixty-seven patients with NAFLD were analyzed. Forty-two of them (62.68%) were female, mean age was 54.76 (±9.63) years, mean body mass index 31.42 (±5.64) and 59 (88.05%) of the 67 cases had glucose intolerance or diabetes. A diagnosis of steatohepatitis was made in 45 (76.27%) of the 59 biopsied patients, and advanced liver fibrosis (stages 3 and 4) was diagnosed in 18 (26.86%) of the 67 patients in the study population. The FIB 4 and NAFLD Fibrosis Score models had a high negative predictive value (93.48% and 93.61%, respectively) in patients with severe liver fibrosis (stages 3 and 4). Conclusion In conclusion, use of the FIB 4 and NAFLD Fibrosis Score models in NAFLD patients allows a diagnosis of severe liver disease to be excluded.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000300276&lng=en&tlng=enNAFLDnonalcoholic steatohepatitismathematical modelliver fibrosisspecialist
spellingShingle Rodrigo Bremer Nones
Cláudia Pontes Ivantes
Maria Lucia Alves Pedroso
Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
Archives of Endocrinology and Metabolism
NAFLD
nonalcoholic steatohepatitis
mathematical model
liver fibrosis
specialist
title Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
title_full Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
title_fullStr Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
title_full_unstemmed Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
title_short Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
title_sort can fib4 and nafld fibrosis scores help endocrinologists refer patients with non alcoholic fat liver disease to a hepatologist
topic NAFLD
nonalcoholic steatohepatitis
mathematical model
liver fibrosis
specialist
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000300276&lng=en&tlng=en
work_keys_str_mv AT rodrigobremernones canfib4andnafldfibrosisscoreshelpendocrinologistsreferpatientswithnonalcoholicfatliverdiseasetoahepatologist
AT claudiapontesivantes canfib4andnafldfibrosisscoreshelpendocrinologistsreferpatientswithnonalcoholicfatliverdiseasetoahepatologist
AT marialuciaalvespedroso canfib4andnafldfibrosisscoreshelpendocrinologistsreferpatientswithnonalcoholicfatliverdiseasetoahepatologist